Substance-related DisordersSSASNCT00690352
Specialized Substance Abuse Supervision (SSAS) Versus Non-SSAS Recidivism Rates Among Nebraska Felony Drug Offenders
An observational study of Substance-related Disorders and Alcohol-related Disorders, run by University of Nebraska at 1 site in United States.
Trial summary
This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who… Read more about this study
- Who is it for?
- Ages 17 years and older
- Conditions the study is for
- Substance-related Disorders, Alcohol-related Disorders
- What is being tested?
- Specialized Substance Abuse Supervision (SSAS)
- Type of treatment
- Lifestyle or therapy programme
- How many people
- 344 participants
- Where
- 1 siteUnited States
- Study dates
- 5 Mar 2008to 20 Aug 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 at any of the five participating SSAS sites in Nebraska, plus matched sets of probationers and parolees who did not participated in SSAS at any of the probation/parole sites in the state of Nebraska.
Who may be able to join
- convicted felony drug offender
- sentenced in Nebraska
- probationer or parolee
- entered probation or parole or SSAS between March 1, 2006 and February 28, 2007
Who cannot join
- convicted felony drug offender sentenced in Nebraska starting probation or parole between March 1, 2006 and February 28, 2007 who does not match SSAS probationers/parolees in terms of age, demographics, urban v. rural residence, and/or class of felony drug offense.
Trial locations and contacts
1 site in 1 country.
United States1 site
University of Nebraska Medical Center
Omaha, Nebraska, 68198
About this study
Official title: Comparing Recidivism Rates of Felony Drug Offenders in Nebraska Who Were Sentenced to, and/or Participated in, Specialized Substance Abuse Supervision (SSAS) to Those Without SSAS
This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who did not participate in SSAS.
Read the detailed description
Since March 2006, Specialized Substance Abuse Supervision (SSAS) has been available at five sites in Nebraska as an enhancement of probation and parole for felony drug offenders whose scores on initial screening instruments warrant such placement. SSAS enhancements to traditional probation and parole include cognitive behavioral therapy (CBT) in groups; use of incentives; positive reinforcement; and motivational interviewing.
Records of probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 were studied to assess recidivism rates. Recidivism for this study is defined as "an arrest and conviction on a new charge while on probation or parole."
The records of a matched control group of non-SSAS probationers and parolees who entered probation or parole during the same time period with similar drug felony offenses and similar screening scores were also studied. Control group was also matched, as much as possible, with similar age group, demographic data, rural/urban residence, and level of felony offense.
Investigators performed a statistical analysis to determine recidivism rates at six months post-entrance to SSAS (and for the control group, at six months post-entrance to probation or parole).
- Being tested
- Specialized Substance Abuse Supervision (SSAS)
- Keywords
- Specialized Substance Abuse Supervision, SSAS, substance use disorder, felony drug offender, probation, parole, cognitive behavioral therapy, CBT
- Medical subject headings
- Substance-Related Disorders, Alcohol-Related Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Specialized Substance Abuse Supervision (SSAS)Behavioural
Also called CBT, motivational interviewing, positive reinforcement, use of incentives
Six months participation in SSAS which may include cognitive behavioral therapy (CBT) in groups; use of incentives, positive reinforcement, and/or motivational interviewing.
What is being measured
The primary outcome is the main question the study is designed to answer.
Recidivism
Proportion of individuals who re-offend during the six months following sentencing
Measured: 6 months
Secondary outcomes (4)
Probation Violation
Percentage of individuals who violated probation during the six months following sentencing
Measured: 6 months
Probation violation with incarceration
Percentage of individuals who violated probation and were incarcerated during the six months following sentencing
Measured: 6 months
Positive drug screens
Percentage of individuals with positive drug screens during the six months following sentencing
Measured: 6 months
Employed
Percentage of individuals employed during the six months following sentencing
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Jun 2008 (estimated)
- Study start5 Mar 2008
- Primary completion6 Jul 2008
- Study completion20 Aug 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Substance-related DisordersStudies of the same condition, open and under way.
- More trials run by University of NebraskaThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case-control
- Time perspective
- Retrospective
- Enrolment
- 344 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Nebraska
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Kathleen M Grant, MD, Principal investigator, University of Nebraska
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00690352
- Sponsor's protocol ID
- 0066-08-FB
- Acronym
- SSAS
- Status last verified
- Sep 2023
- First submitted
- 6 May 2008
- Last updated
- 25 Sep 2023
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 25 Sep 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comparing Recidivism Rates of Felony Drug Offenders in Nebraska Who Were Sentenced to, and/or Participated in, Specialized Substance Abuse Supervision (SSAS) to Those Without SSAS
- ClinicalTrials.gov ID
- NCT00690352
- Acronym / sponsor ID
- SSAS / 0066-08-FB
- Keywords
- Specialized Substance Abuse Supervision, SSAS, substance use disorder, felony drug offender, probation, parole, cognitive behavioral therapy, CBT
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 344 participants (actual)
- Lead sponsor
- University of NebraskaUniversity, hospital or other
- Study start
- 5 Mar 2008 (actual)
- Primary completion
- 6 Jul 2008 (actual)
- Study completion
- 20 Aug 2008 (actual)
- First posted
- 4 Jun 2008 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This social science study hypothesizes that convicted felony drug offenders in Nebraska who participated in Specialized Substance Abuse Supervision (SSAS) as part of their probation or parole showed significantly better outcomes (specifically, less recidivism) at six months post-entrance to SSAS compared to those who did not participate in SSAS.
Detailed description
Since March 2006, Specialized Substance Abuse Supervision (SSAS) has been available at five sites in Nebraska as an enhancement of probation and parole for felony drug offenders whose scores on initial screening instruments warrant such placement. SSAS enhancements to traditional probation and parole include cognitive behavioral therapy (CBT) in groups; use of incentives; positive reinforcement; and motivational interviewing.
Records of probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 were studied to assess recidivism rates. Recidivism for this study is defined as "an arrest and conviction on a new charge while on probation or parole."
The records of a matched control group of non-SSAS probationers and parolees who entered probation or parole during the same time period with similar drug felony offenses and similar screening scores were also studied. Control group was also matched, as much as possible, with similar age group, demographic data, rural/urban residence, and level of felony offense.
Investigators performed a statistical analysis to determine recidivism rates at six months post-entrance to SSAS (and for the control group, at six months post-entrance to probation or parole).
Study design
- Observational model
- Case-control
- Time perspective
- Retrospective
Who may qualify
- Ages
- 17 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Probationers and parolees who participated in SSAS starting anytime between March 1, 2006 and February 28, 2007 at any of the five participating SSAS sites in Nebraska, plus matched sets of probationers and parolees who did not participated in SSAS at any of the probation/parole sites in the state of Nebraska.
Key inclusion criteria (4 listed)
- convicted felony drug offender
- sentenced in Nebraska
- probationer or parolee
- entered probation or parole or SSAS between March 1, 2006 and February 28, 2007
Key exclusion criteria (1 listed)
- convicted felony drug offender sentenced in Nebraska starting probation or parole between March 1, 2006 and February 28, 2007 who does not match SSAS probationers/parolees in terms of age, demographics, urban v. rural residence, and/or class of felony drug offense.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Specialized Substance Abuse Supervision (SSAS)Also: CBT, motivational interviewing, positive reinforcement, use of incentivesSix months participation in SSAS which may include cognitive behavioral therapy (CBT) in groups; use of incentives, positive reinforcement, and/or motivational interviewing. | Behavioural | – |
Primary outcome
Recidivism
Time frame: 6 months
Proportion of individuals who re-offend during the six months following sentencing
4 secondary outcomes
Probation Violation
Time frame: 6 months
Probation violation with incarceration
Time frame: 6 months
Positive drug screens
Time frame: 6 months
Employed
Time frame: 6 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 Sep 2023.
Related trials for Substance-related Disorders
Not yet recruiting
Prescribe to Prevent HIV: A Hybrid Trial Helping Addiction Clinics Prevent HIV & Infections Through Safer Drug Use Support
People Who Use Opioids/People With Opioid Use Disorder (OUD)
Enrolling by invitationObservational study
Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl
Substance Use Disorders (SUDs)
Recruiting
Trial Phase: Syndemic Adapted Medly Uganda
Mental Health
RecruitingObservational study
Olfactory Function and Model-Based Behavior in People Living With HIV and SUD
HIV, Substance Use Disorder
Not yet recruiting
Substance Use and Media Preferences
Substance Use Behavior, Cannabis Intoxication
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kathleen M Grant, MD principal investigator
University of Nebraska
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Substance-related Disorders and Alcohol-related Disorders, run by University of Nebraska at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recidivism (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Sep 2023.